COMP <GO>
IREN vs CHYM // FORWARD P/E MULTIPLE
IREN Limited (NASDAQ) VS. Chime Financial Inc. (NASDAQ) • 15-METRIC TALLY: IREN 6
— CHYM 4
▲ FORWARD P/E MULTIPLE LEADER: CHYM
LAST: $23.95 (-8.76%) • MKT CAP: $10.62B
forward-pe
102.6x
LAST: $27.95 (-3.19%) • MKT CAP: $10.93B
forward-pe
22.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. CHYM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | CHYM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | -35.00% | +36.20 | IREN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | -0.42% | -2.66 | CHYM | /fcf-yield <GO> |
| Operating Margin | 3.50% | -47.60% | +51.10 | IREN | /operating-margins <GO> |
| Net Profit Margin | 17.40% | -46.20% | +63.60 | IREN | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 30.70% | +137.00 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 48.0 | -10.70 | CHYM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.91 | +0.17 | IREN | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 102.6x | 22.0x | +80.60 | CHYM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $10.93B | -$308.6M | CHYM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | CHYM REV | IREN GROSS % | CHYM GROSS % | IREN FCF | CHYM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $2.19B | 68.3% | 88.0% | -$327.6M | -$45.6M |
| FY 2024 | $187.2M | $1.67B | 53.5% | 87.6% | -$89.6M | -$11.2M |
| FY 2023 | $75.5M | $1.28B | — | — | $2.3M | -$214.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
CHYM // BETA 0.91